6981 - 6990 of 8808 Results
Title
Year
-
OPENTitle: Activation and Purification of ß‐Glucocerebrosidase by Exploiting its Transporter LIMP‐2 – Implications for Novel Treatment Strategies in Gaucher's and Parkinson's DiseaseJournal Name: Advanced SciencePublisher: WileyVol: 11Issue #: 25Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/advs.202401641Best OA location URL: https://doi.org/10.1002/advs.202401641Citation Count: 3
-
RESTRICTEDTitle: A novel brain penetrant c-Abl tyrosine kinase inhibitor: Paving a path forward to success in disease modification in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 108Issue #:Start Page: 105325End Page: 105325Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105325Citation Count: 0
-
OPENTitle: Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 10Issue #: 10Start Page: 898End Page: 908Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(11)70175-2Best OA location URL: http://www.thelancet.com/article/S1474442211701752/pdfCitation Count: 325
- Effects of Parkin on the Mitochondrial Genome in the Heart and Brain of Mitochondrial Mutator Mice2023OPENTitle: Effects of Parkin on the Mitochondrial Genome in the Heart and Brain of Mitochondrial Mutator MiceJournal Name: Advanced BiologyPublisher: WileyVol: 7Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/adbi.202300154Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/adbi.202300154Citation Count: 2
-
OPENTitle: A Novel α‐Synuclein K58N Missense Variant in a Patient with Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.70030Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70030Citation Count: 0
-
OPENTitle: Validation of human microRNA target pathways enables evaluation of target prediction toolsJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 49Issue #: 1Start Page: 127End Page: 144Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/nar/gkaa1161Best OA location URL: https://academic.oup.com/nar/article-pdf/49/1/127/35597117/gkaa1161.pdfCitation Count: 58
-
OPENTitle: Perceived Discrimination in Health Care for LGBTQIA+ People Living With Parkinson’s DiseaseJournal Name: The Journals of Gerontology: Series BPublisher: Oxford University Press (OUP)Vol: 78Issue #: 9Start Page: 1459End Page: 1465Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/geronb/gbad046Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10461524/pdf/gbad046.pdfCitation Count: 9
-
OPENTitle: NMDA receptor blockade ameliorates abnormalities of spike firing of subthalamic nucleus neurons in a parkinsonian nonhuman primateJournal Name: Journal of Neuroscience ResearchPublisher: WileyVol: 96Issue #: 7Start Page: 1324End Page: 1335Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/jnr.24230Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5980712Citation Count: 26
-
OPENTitle: Subthalamic nucleus—sensorimotor cortex functional connectivity in de novo and moderate Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 1Start Page: 462End Page: 469Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.07.004Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.07.004Citation Count: 47
-
RESTRICTEDTitle: Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4418Citation Count: 0